EASD

Showing 2 posts of 2 posts found.

Jardiance

More positive CV data for Boehringer and Lilly’s Jardiance

September 21, 2015
Research and Development, Sales and Marketing Boehringer Ingelheim, EASD, Eli Lilly, cardiovascular risk, empagliflozin, jardiance, mortality risk, type 2 diabetes

Jardiance, an anti-diabetes drug produced by Boehringer Ingelheim and Eli Lilly, reduces the risk of death in people with type …

forxiga

AstraZeneca scores positive real-world Forxiga data

September 16, 2015
Research and Development AstraZeneca, EASD, European Association for the Study of Diabetes, Forxiga, dapagliflozin, exenatide, real world data, real world evidence

The real-world study of AstraZeneca’s diabetes drug Forxiga has found its use in UK patients primary care patients supports the …

The Gateway to Local Adoption Series

Latest content